
Release date: 2024-08-14 16:33:54 Article From: Lucius Laos Recommended: 299
Pemigatinib is a targeted therapy drug that is of great significance in the treatment of cholangiocarcinoma.
Any medication can have some side effects while treating the disease. Side effects of Pemigatinib vary from individual to individual and may include, but are not limited to:
Digestive reactions, skin and nail problems, eye problems, electrolyte abnormalities, systemic reactions, and other serious reactions.
Patients should fully understand the potential side effects of Pemigatinib before receiving treatment and standardize the use of the drug under the guidance of a doctor. At the same time, patients should pay close attention to their physical condition, seek medical attention, and inform the doctor if they have any discomfort. Doctors will adjust the dosage or treatment regimen according to the patient's specific situation to minimize side effects and improve the effectiveness of treatment.
When using Pemigatinib, patients may experience a range of gastrointestinal reactions. These reactions include, but are not limited to, the following:
This is one of the most common side effects of Pemigatinib, and patients may experience varying degrees of diarrhea.
Some patients experience nausea accompanied by vomiting, which may affect appetite and nutrient intake.
It is manifested as epigastric discomfort and fullness, which affects the comfort of the patient.
The gastrointestinal reactions that may be caused by Pemigatinib during treatment require the joint attention of patients and doctors, and appropriate measures should be taken to mitigate or prevent these adverse reactions.
Patients should try to avoid spicy, greasy, raw, and cold irritating foods, which may increase the burden on the gastrointestinal tract and lead to worsening symptoms such as diarrhea, nausea, and vomiting.
Patients are advised to eat more easily digestible and nutritious foods, such as porridge, noodles, vegetables, etc., to reduce the burden on the gastrointestinal tract and promote digestion and absorption.
Pemigatinib may have some effects on the liver, and patients should regularly review liver function indicators, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), etc., to understand liver health.
【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:3492025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:5512024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:3362025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:3502025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:3262025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:3922025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:3252025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:3002025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643